Abeona Therapeutics, Inc. (ABEO)
5.85
-0.07
(-1.18%)
USD |
NASDAQ |
Aug 31, 16:00
5.86
+0.01
(+0.17%)
Pre-Market: 20:00
Abeona Therapeutics Cash from Investing (Quarterly) : 15.69M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.69M |
| March 31, 2026 | 4.963M |
| December 31, 2025 | 9.554M |
| September 30, 2025 | -64.63M |
| June 30, 2025 | 155.89M |
| March 31, 2025 | 4.213M |
| December 31, 2024 | 18.88M |
| September 30, 2024 | -6.167M |
| June 30, 2024 | -44.13M |
| March 31, 2024 | -7.817M |
| December 31, 2023 | 11.53M |
| September 30, 2023 | -18.74M |
| June 30, 2023 | 5.211M |
| March 31, 2023 | 2.211M |
| December 31, 2022 | -25.29M |
| September 30, 2022 | 1.649M |
| June 30, 2022 | -1.398M |
| March 31, 2022 | 1.075M |
| December 31, 2021 | 7.999M |
| September 30, 2021 | 26.76M |
| June 30, 2021 | 21.92M |
| March 31, 2021 | 9.376M |
| December 31, 2020 | 5.782M |
| September 30, 2020 | 4.584M |
| June 30, 2020 | -18.21M |
| Date | Value |
|---|---|
| March 31, 2020 | -75.87M |
| December 31, 2019 | -0.946M |
| September 30, 2019 | 19.23M |
| June 30, 2019 | 18.92M |
| March 31, 2019 | 22.77M |
| December 31, 2018 | |
| September 30, 2018 | -10.43M |
| June 30, 2018 | -73.27M |
| March 31, 2018 | -3.502M |
| December 31, 2017 | -0.704M |
| September 30, 2017 | -0.072M |
| June 30, 2017 | -0.01M |
| March 31, 2017 | -0.074M |
| December 31, 2016 | -0.018M |
| September 30, 2016 | -0.148M |
| June 30, 2016 | -0.126M |
| March 31, 2016 | -0.227M |
| December 31, 2015 | -0.267M |
| September 30, 2015 | -0.027M |
| June 30, 2015 | 3.692M |
| March 31, 2015 | -0.009M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Forum Markets, Inc. | -17.79M |
| Corcept Therapeutics, Inc. | -29.24M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.50M |
| Cash from Financing (Quarterly) | -3.335M |
| Free Cash Flow | -81.53M |
| Free Cash Flow Per Share (Quarterly) | -0.3151 |
| Free Cash Flow to Equity (Quarterly) | -14.67M |
| Free Cash Flow to Firm (Quarterly) | -17.28M |
| Free Cash Flow Yield | -25.00% |